Aprea Therapeutics, Inc. (APRE) income statement
APRENasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30
$0.49+0.03 (+6.07%)
Close on Nov 19, 2026Market cap $6.21MP/E –Yield –
Aprea Therapeutics, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- -79.4%
Financial strength
- Current ratio
- 13.55
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 1333.4%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.16
- Dividend yield
- –
See a number that looks wrong?